Cargando…
Novel Therapeutic Options for Small Cell Lung Cancer
PURPOSE OF REVIEW: The aim of this review is to focus on the recent advances in the molecular knowledge of small cell lung cancer (SCLC) and potential promising new treatment strategies, like targeting the DNA damage pathway, epigenetics, angiogenesis, and oncogenic drivers. RECENT FINDINGS: In the...
Autores principales: | Canova, Stefania, Trevisan, Benedetta, Abbate, Maria Ida, Colonese, Francesca, Sala, Luca, Baggi, Alice, Bianchi, Sofia Paola, D’Agostino, Anna, Cortinovis, Diego Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10640463/ https://www.ncbi.nlm.nih.gov/pubmed/37870696 http://dx.doi.org/10.1007/s11912-023-01465-7 |
Ejemplares similares
-
Harnessing DLL3 inhibition: From old promises to new therapeutic horizons
por: Cortinovis, Diego Luigi, et al.
Publicado: (2022) -
Duration of Immunotherapy in Non-Small Cell Lung Cancer Survivors: A Lifelong Commitment?
por: Putzu, Carlo, et al.
Publicado: (2023) -
Focus on Nivolumab in NSCLC
por: Cortinovis, Diego L., et al.
Publicado: (2016) -
Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma
por: Cortinovis, Diego, et al.
Publicado: (2021) -
Targeted therapies and immunotherapy in non-small-cell lung cancer
por: Cortinovis, D, et al.
Publicado: (2016)